| Aug 14 |
Why Nkarta Stock Is Soaring Today
|
| Aug 14 |
Nkarta upgraded at Raymond James on valuation
|
| Aug 14 |
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
|
| Aug 14 |
Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
|
| Aug 13 |
Nkarta GAAP EPS of -$0.34 beats by $0.13
|
| Aug 13 |
Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
|
| Jul 24 |
Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus
|
| Jul 16 |
Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President
|
| Jul 10 |
Nkarta (NKTX) Upgraded to Buy: Here's What You Should Know
|
| Jun 27 |
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications
|
